Clinical trial
Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or…
NCT00251303 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00251303 |
|---|---|
| Title | Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders |
| Official title | An Investigation of the Efficacy in Childhood Obsessive-Compulsive Disorder of Riluzole: An Antiglutamatergic Agent |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obsessive-Compulsive Disorder, Autism Spectrum Disorder, Autism, Asperger Disorder, Developmental Disorder |
| Intervention type | Drug |
| Interventions | Riluzole, Placebo |
| Enrollment | 78 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2012 |
| Completion | Feb 1, 2012 |
| First posted | Nov 9, 2005 |
| Last update posted | Jul 15, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: